tiprankstipranks
PreveCeutical Updates on Financial Report Delay
Company Announcements

PreveCeutical Updates on Financial Report Delay

PreveCeutical Medical (TSE:PREV) has released an update.

Don't Miss our Black Friday Offers:

PreveCeutical Medical Inc. announced an update on the Management Cease Trade Order, citing a delay in filing their 2023 annual financial reports due to funding issues. They have since secured funds through a private placement and expect to complete the filings by June 28, 2024. Trading continues for the general public, but restrictions apply to company insiders until filings are complete.

For further insights into TSE:PREV stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskPreveCeutical Welcomes Expert to Boost Health Research
TipRanks Canadian Auto-Generated NewsdeskPreveCeutical’s BioGene Announces Key Leadership Appointments
TipRanks Canadian Auto-Generated NewsdeskPreveCeutical Finalizes BioGene Asset Deal
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App